For New Drugs, Manufacturers are Becoming Payers: 2022 Asembia Specialty Pharmacy Summit

May 03, 2022

IQVIA’s Lucas Greenwalt says manufacturers need to provide patient assistance if they want their new brands to meet sales goals as payers devise strategies to cope with cost and the increasing number of ultra-expensive medications skyrockets.

Federal, state legislative prospects discussed: Asembia 2022 Specialty Pharmacy Summit

May 03, 2022

The Build Back Better legislation would have had far-reaching effects on Medicare Parts B and D but the legislation has stalled, and it is unclear if any significant federal legislation affecting specialty pharamcy will pass this year. Meanwhile, several states are addressing white bagging, according to Tracy Russell of CoverMyMeds.

Tracy Russell of CoverMyMeds Addresses Efforts Upcoming in Specialty Pharmacy

May 02, 2022

Tracy Russell, senior director of state government affairs at CoverMyMeds addressed what piece of new federal legislation will have the biggest effect on specialty pharmacy and what the Biden administration's emphasis on healthcare equity will do for specialty pharmacy. Russell spoke more on this topic at this year's Asembia Specialty Pharmacy Summit in Las Vegas.

Asembia 2021: A Futuristic Vision of Specialty Pharmacy

October 29, 2021

3D printing of drugs at home. Simulated drug combinations. Treatments tailored to microbiomes. Deloitte’s George Van Antwerp spun some futuristic scenarios for pharmacy and healthcare at the Asembia specialty pharmacy meeting in Las Vegas.

Asembia 2021: Explaining REMS Benefits. No Need for the Dread.

October 29, 2021

Risk Evaluation and Mitigation Strategies (REMS) programs are designed to protect patients, but they can also make providers more confident about prescribing a drug, explained panelists at the Asembia specialty pharmacy meeting. And the FDA collaborates with drugmakers on the planning the particulars of the programs, said Steve Granzyk and Tiffany Abraham.